Amram Dahukey, DPM
Podiatrist · Tucson, AZNPI 1366592867
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Metric Medical Devices, Inc. at 58.8% of the total. Reporting peaked in 2019 at $2,284 and has fallen 97.4% since, to $60 in 2025.
Across 33 payments — averaging $105.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Metric Medical Devices, Inc.$2K
- Organogenesis Inc.$203
- Zimmer Biomet$183
- Paratek Pharmaceuticals, Inc.$132
- Osiris Therapeutics Inc.$128
- Next Science LLC$125
- plus $660 from 12 others
What the payments were for
- Speaking & faculty fees$1,50043%
- Travel & lodging$1685%
- Food & beverage$1,80652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Metric Medical Devices, Inc. | 6 | $2,043 |
| Organogenesis Inc. | 1 | $203 |
| Zimmer Biomet | 2 | $183 |
| Paratek Pharmaceuticals, Inc. | 2 | $132 |
| Osiris Therapeutics Inc. | 3 | $128 |
| Next Science LLC | 1 | $125 |
| Flower Orthopedics Coporation | 1 | $118 |
| Smith+Nephew | 3 | $107 |
| Parcus Medical, LLC | 1 | $93 |
| Anika Therapeutics, Inc. | 1 | $81 |
| Stryker | 1 | $60 |
| Derma Sciences, Inc. | 1 | $42 |
| Orthofix Medical, Inc. | 4 | $41 |
| Averitas Pharma Inc. | 2 | $40 |
| AbbVie | 1 | $26 |
| Davol Inc. | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $19 |
| Misonix Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,474 in reported general payments places this provider in the 80th percentile of 151 podiatrist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 67 | $564 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 24 | $524 |
| Ondansetron Hcl | 18 | $163 |
| Doxycycline Hyclate | 12 | $116 |
| Gabapentin | 19 | $115 |
| Tramadol Hcl | 20 | $75 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Tucson
- Barbara AungTucson$77K
- Alan ShihTucson$2K
- Steven HollanderTucson$2K
- Carrie HessTucson$2K
- Kris DinucciScottsdale$1.4M
- Lewis FreedMesa$997K
- Stephen KominskySun City West$508K
- Chad WestphalPeoria$300K
- Kerry ZangMesa$111K
- Todd HaddonMesa$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.